MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Harvard Bioscience Accounts Payables 2011-2026 | HBIO
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.65 M | 4.79 M | 5.55 M | 6.45 M | 4.91 M | 5.97 M | 5.34 M | 7.36 M | 5.4 M | 6.2 M | 8.78 M | 6.29 M | 4.68 M | 4.68 M | 4.96 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.78 M | 3.65 M | 5.67 M |
Quarterly Accounts Payables Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.18 M | 4.72 M | 4.81 M | 4.79 M | 5.28 M | 5.71 M | 6.04 M | 5.55 M | 6.27 M | 4.72 M | 5.98 M | 6.45 M | - | - | 6.22 M | 4.91 M | 5.62 M | 7.49 M | 6.42 M | 5.97 M | 5.97 M | 5.97 M | 5.97 M | 5.34 M | 5.34 M | 5.34 M | 5.34 M | 7.36 M | 7.36 M | 7.36 M | 7.36 M | 4.41 M | 4.41 M | 4.41 M | 4.41 M | 6.2 M | 6.2 M | 6.2 M | 6.2 M | 8.78 M | 8.78 M | 8.78 M | 8.78 M | 6.29 M | 6.29 M | 6.29 M | 6.29 M | 4.68 M | 4.68 M | 4.88 M | 4.68 M | 4.68 M | 4.68 M | 4.68 M | 4.68 M | 4.96 M | 4.96 M | 4.96 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.78 M | 4.41 M | 5.82 M |
Accounts Payables of other stocks in the Medical instruments industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
999 M | $ 16.55 | -0.63 % | $ 8.49 B |  USA |
 |
Atrion Corporation
ATRI
|
6.63 K | - | - | $ 810 M | USA |
 |
The Cooper Companies
COO
|
300 M | $ 68.85 | -2.06 % | $ 13.7 B | USA |
 |
electroCore
ECOR
|
2.71 M | $ 6.76 | -4.05 % | $ 57.3 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
1.43 M | $ 9.14 | -6.26 % | $ 22.2 M | USA |
 |
BioLife Solutions
BLFS
|
3.57 M | $ 18.62 | -3.37 % | $ 858 M | USA |
 |
Glaukos Corporation
GKOS
|
13.4 M | $ 116.32 | -0.36 % | $ 5.63 B | USA |
 |
AtriCure
ATRC
|
25.3 M | $ 29.09 | -0.34 % | $ 1.39 B | USA |
 |
Haemonetics Corporation
HAE
|
67 M | $ 59.06 | 1.1 % | $ 2.97 B | USA |
 |
iRhythm Technologies
IRTC
|
2.26 M | $ 116.43 | -0.68 % | $ 3.73 B | USA |
 |
Repro Med Systems
KRMD
|
2.27 M | $ 4.26 | - | $ 197 M | USA |
 |
Masimo Corporation
MASI
|
253 M | $ 178.36 | -0.07 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
511 K | $ 2.29 | -2.97 % | $ 105 M |  Israel |
 |
Milestone Scientific
MLSS
|
780 K | $ 0.29 | 1.38 % | $ 23.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
192 M | $ 24.99 | -3.21 % | $ 4.2 B | USA |
 |
Pro-Dex
PDEX
|
4.61 M | $ 50.03 | 3.09 % | $ 164 M | USA |
 |
ResMed
RMD
|
159 M | $ 223.41 | -0.62 % | $ 32.6 B | USA |
 |
ICU Medical
ICUI
|
154 M | $ 121.46 | -1.24 % | $ 2.99 B | USA |
 |
Retractable Technologies
RVP
|
5.34 M | $ 0.72 | 1.45 % | $ 21.6 M | USA |
 |
InfuSystem Holdings
INFU
|
8.34 M | $ 9.41 | -0.21 % | $ 194 M | USA |
 |
Intuitive Surgical
ISRG
|
255 M | $ 450.18 | -0.53 % | $ 161 B | USA |
 |
STAAR Surgical Company
STAA
|
11.6 M | $ 21.38 | 2.0 % | $ 1.06 B | USA |
 |
Stereotaxis
STXS
|
4.77 M | $ 1.86 | -1.59 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
3.65 M | $ 109.87 | 0.65 % | $ 2.49 B | USA |
 |
Teleflex Incorporated
TFX
|
130 M | $ 115.67 | 0.51 % | $ 5.16 B | USA |
 |
Merit Medical Systems
MMSI
|
60.6 M | $ 68.33 | 0.77 % | $ 4.04 B | USA |
 |
Utah Medical Products
UTMD
|
911 K | $ 63.75 | 1.3 % | $ 207 M | USA |
 |
Predictive Oncology
POAI
|
1.84 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
2.78 M | $ 19.27 | -16.0 % | $ 1.3 B | USA |
 |
West Pharmaceutical Services
WST
|
254 M | $ 257.61 | 0.25 % | $ 18.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
300 M | $ 11.46 | -1.55 % | $ 2.29 B | USA |
 |
NeuroMetrix
NURO
|
363 K | - | 5.05 % | $ 9.02 M | USA |
 |
STERIS plc
STE
|
281 M | $ 218.23 | -0.8 % | $ 21.5 B | USA |
 |
AngioDynamics
ANGO
|
33.3 M | $ 9.44 | -4.07 % | $ 386 M | USA |
 |
Becton, Dickinson and Company
BDX
|
1.97 B | $ 154.93 | -0.2 % | $ 44.6 B | USA |
 |
Nephros
NEPH
|
873 K | $ 2.73 | -4.55 % | $ 28.4 M | USA |
 |
OraSure Technologies
OSUR
|
6.52 M | $ 3.03 | -1.79 % | $ 223 M | USA |
 |
Repligen Corporation
RGEN
|
19.6 M | $ 114.82 | -1.82 % | $ 6.4 M | USA |